Microfluidic enrichment for the single cell analysis of circulating tumor cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yeo, Trifanny ^a   Tan, Swee Jin ^a   Lim, Chew Leng ^b   Lau, Dawn Ping Xi ^c   Chua, Yong Wei ^d   Krisna, Sai Sakktee ^c   Iyer, Gopal ^c   Tan, Gek San ^d   Lim, Tony Kiat Hon ^d   Tan, Daniel S W ^c,e   Lim, Wan Teck ^c,f,g   Lim, Chwee Teck ^h,i  

^a Clearbridge Biomedics   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

^g INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR;

CARCINOMA, NON-SMALL-CELL LUNG; CELL SEPARATION; DEVICES; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN; LAB ON A CHIP; LUNG NEOPLASMS; MCF-7 CELL LINE; METABOLISM; MICROFLUIDIC ANALYSIS; MUTATION; PATHOLOGY; PROCEDURES; SINGLE CELL ANALYSIS; TUMOR CELL LINE; TUMOR EMBOLISM;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; HUMANS; LAB-ON-A-CHIP DEVICES; LUNG NEOPLASMS; MCF-7 CELLS; MICROFLUIDIC ANALYTICAL TECHNIQUES; MUTATION; NEOPLASTIC CELLS, CIRCULATING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE-CELL ANALYSIS;

EID: 84988596473     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22076     Document Type: Article

References (64)

1. Schubert, C. Single-cell analysis: The deepest differences. Nature 480, 133-137 (2011).
2. Hughes, W. H. Variation in penicillin resistance in single-cell cultures of Staphylococcus aureus. J Gen Microbiol 6, 175-180 (1952).
3. Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M. & Sorger, P. K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459, 428-432 (2009).
4. Adalsteinsson, V. A. et al. Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR + CXC chemokines. Integr Biol (Camb) 5, 1272-1281 (2013).
5. Buettner, F. et al. Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells. Nat Biotechnol 33, 155-160 (2015).
6. Miething, C. et al. PTEN action in leukaemia dictated by the tissue microenvironment. Nature 510, 402-406 (2014).
7. Blainey, P. C. & Quake, S. R. Dissecting genomic diversity, one cell at a time. Nat Meth 11, 19-21 (2014).
8. Wang, J., Fan, H. C., Behr, B. & Quake, S. R. Genome-wide single-cell analysis of recombination activity and de novo mutation rates in human sperm. Cell 150, 402-412 (2012).
9. Bendall, S. C. & Nolan, G. P. From single cells to deep phenotypes in cancer. Nat Biotechnol 30, 639-647 (2012).
10. Spencer, S. L. & Sorger, P. K. Measuring and modeling apoptosis in single cells. Cell 144, 926-939 (2011).
11. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313 (2012).
12. Solomon, B. J. et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371, 2167-2177 (2014).
13. Vincent, M. Cancer: a de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer. Bioessays 34, 72-82 (2012).
14. Navin, N. & Hicks, J. Future medical applications of single-cell sequencing in cancer. Genome Med 3, 31 (2011).
15. Navin, N. et al. Inferring tumor progression from genomic heterogeneity. Genome Res 20, 68-80 (2010).
16. Siravegna, G. et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med advance online publication (2015).
17. Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature advance online publication (2015).
18. Bedard, P. L., Hansen, A. R., Ratain, M. J. & Siu, L. L. Tumour heterogeneity in the clinic. Nature 501, 355-364 (2013).
19. Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338-345 (2013).
20. Hiley, C., de Bruin, E. C., McGranahan, N. & Swanton, C. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol 15, 453 (2014).
21. Maheswaran, S. & Haber, D. A. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 20, 96-99 (2010).
22. Hodgkinson, C. L. et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20, 897-903 (2014).
23. Kling, J. Beyond counting tumor cells. Nat Biotechnol 30, 578-580 (2012).
24. Budd, G. T. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Mol Pharm 6, 1307-1310 (2009).
25. Powell, A. A. et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 7, e33788 (2012).
26. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
27. Ozkumur, E. et al. Inertial focusing for tumor antigen-dependent and-independent sorting of rare circulating tumor cells. Sci Transl Med 5, 179ra147 (2013).
28. Reategui, E. et al. Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells. Adv Mater 27, 1593-1599 (2015).
29. Hou, H. W. et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep 3, 1259 (2013).
30. Tan, S. J., Yobas, L., Lee, G. Y., Ong, C. N. & Lim, C. T. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 11, 883-892 (2009).
31. Karabacak, N. M. et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat. Protocols 9, 694-710 (2014).
32. Mach, A. J., Kim, J. H., Arshi, A., Hur, S. C. & Di Carlo, D. Automated cellular sample preparation using a Centrifuge-on-a-Chip. Lab Chip 11, 2827-2834 (2011).
33. Punnoose, E. A. et al. Molecular biomarker analyses using circulating tumor cells. PLoS One 5, e12517 (2010).
34. Barriere, G., Riouallon, A., Renaudie, J., Tartary, M. & Rigaud, M. Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer 12, 114 (2012).
35. Lustberg, M. B. et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Breast Cancer Res 16, R23 (2014).
36. Punnoose, E. A. et al. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18, 2391-2401 (2012).
37. Marchetti, A. et al. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment. PLoS One 9, e103883 (2014).
38. Maheswaran, S. et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359, 366-377 (2008).
39. Swennenhuis, J. F., Reumers, J., Thys, K., Aerssens, J. & Terstappen, L. W. Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS. Genome Med 5, 106 (2013).
40. Neves, R. P. et al. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer. Clin Chem 60, 1290-1297 (2014).
41. Dey, S. S., Kester, L., Spanjaard, B., Bienko, M. & van Oudenaarden, A. Integrated genome and transcriptome sequencing of the same cell. Nat Biotechnol 33, 285-289 (2015).
42. Stoecklein, N. H. et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 13, 441-453 (2008).
43. Kehr, J. Single cell technology. Curr Opin Plant Biol 6, 617-621 (2003).
44. Peeters, D. J. E. et al. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. Br J Cancer 108, 1358-1367 (2013).
45. White, A. K. et al. High-throughput microfluidic single-cell RT-qPCR. Proc Natl Acad Sci USA 108, 13999-14004 (2011).
46. Yang, Y. et al. Microfluidic device for DNA amplification of single cancer cells isolated from whole blood by self-seeding microwells. Lab Chip 15, 4331-4337 (2015).
47. Swennenhuis, J. F. et al. Self-seeding microwell chip for the isolation and characterization of single cells. Lab Chip 15, 3039-3046 (2015).
48. Robert, D. et al. Cell sorting by endocytotic capacity in a microfluidic magnetophoresis device. Lab Chip 11, 1902-1910 (2011).
49. Lee, S. S. et al. Quantitative and dynamic assay of single cell chemotaxis. Integr Biol (Camb) 4, 381-390 (2012).
50. Kortmann, H., Kurth, F., Blank, L. M., Dittrich, P. S. & Schmid, A. Towards real time analysis of protein secretion from single cells. Lab Chip 9, 3047-3049 (2009).
51. Zhang, H. & Grinstaff, M. W. Recent advances in glycerol polymers: chemistry and biomedical applications. Macromol Rapid Commun 35, 1906-1924 (2014).
52. Liu, X. Y., Nothias, J. M., Scavone, A., Garfinkel, M. & Millis, J. M. Biocompatibility investigation of polyethylene glycol and alginatepoly-L-lysine for islet encapsulation. ASAIO J 56, 241-245 (2010).
53. Ma, C., Wei, S. & Song, Y. T790M and acquired resistance of EGFR TKI: a literature review of clinical reports. J Thorac Dis 3, 10-18 (2011).
54. Meador, C. B. & Lovly, C. M. Liquid biopsies reveal the dynamic nature of resistance mechanisms in solid tumors. Nat Med 21, 663-665 (2015).
55. Thorsen, T., Roberts, R. W., Arnold, F. H. & Quake, S. R. Dynamic pattern formation in a vesicle-generating microfluidic device. Phys Rev Lett 86, 4163-4166 (2001).
56. Kovarik, M. L. et al. Micro total analysis systems for cell biology and biochemical assays. Anal Chem 84, 516-540 (2012).
57. Guo, M. T., Rotem, A., Heyman, J. A. & Weitz, D. A. Droplet microfluidics for high-throughput biological assays. Lab Chip 12, 2146-2155 (2012).
58. Xuan, X., Zhu, J. & Church, C. Particle focusing in microfluidic devices. Microfluidics and Nanofluidics 9, 1-16 (2010).
59. Piotrowska, Z. et al. Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790MPositive Cancers with a Third-Generation EGFR Inhibitor. Cancer Discov 5, 713-722 (2015).
60. Boshuizen, R., Kuhn, P. & van den Heuvel, M. Circulating tumor cells in non-small cell lung carcinoma. J Thorac Dis 4, 456-458 (2012).
61. Muinelo-Romay, L. et al. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers (Basel) 6, 153 (2014).
62. Wang, Z. et al. Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC. PLoS One 9, e110780 (2014).
63. Xia, Y. & Whitesides, G. M. Soft Lithography. Annual Review of Materials Science 28, 153-184 (1998).
64. Yamamoto, C. et al. Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations. Cancer Res 70, 8715-8725 (2010).